RecruitingNot ApplicableNCT05451901

Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis

Immediate Necrosectomy vs. Step-up Approach After EUS-guided Drainage of Walled-off Necrosis: a Multicenter Randomized Controlled Trial (WONDER-01)


Sponsor

Tokyo University

Enrollment

70 participants

Start Date

Jul 29, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Walled-off necrosis (WON) is a pancreatic fluid collection, which contains necrotic tissue after four weeks of the onset of acute pancreatitis. Interventions are required to manage patients with infected WON, for which endoscopic ultrasonography (EUS)-guided drainage has become a first-line treatment modality. For patients who are refractory to EUS-guided drainage, the step-up treatment including endoscopic necrosectomy (EN) and/or additional drainage is considered to subside the infection. Recent evidence suggests that EN immediately after EUS-guided drainage may shorten treatment duration without increasing adverse events. In this randomized trial, the investigators will compare treatment duration between EN immediately after EUS-guided drainage versus the step-up approach in patients with symptomatic WON.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Patients with WON defined according to the revised Atlanta classification
  • The longest diameter of WON is 4 cm or larger
  • Patients with at least one out of the following conditions; signs of infection, gastrointestinal symptoms, abdominal symptoms, obstructive jaundice
  • Patients who need drainage for WON
  • Age of 18 years or older
  • Patients or their representatives provide informed consent
  • Patients who visit or are hospitalized at the participating institutions

Exclusion Criteria7

  • WON inaccessible by EUS-guided approach
  • AXIOS stent has already been placed into the WON prior to the enrollment
  • Severe coagulopathy; Platelet count \< 50,000/mm3 or prothrombin time international normalized ratio (PT-INR) \>1.5
  • Patients on antithrombotic agents which cannot be managed according to the "guideline for gastroenterological endoscopy in patients undergoing antithrombotic treatment (Dig Endosc. 2014 Jan;26(1):1-14.)"
  • Patients who cannot tolerate endoscopic procedures
  • Pregnant women
  • Patients considered inappropriate for inclusion by investigators

Interventions

PROCEDUREImmediate necrosectomy

Endoscopic ultrasonography (EUS)-guided drainage will be conducted within 72 hours from randomization. A convex-type echoendoscope is advanced to the stomach or duodenum, and the walled-off necrosis (WON) is visualized and punctured under EUS guidance. A lumen-apposing metal stent (LAMS), such as Hot AXIOS system (Boston Scientific Japan, Tokyo, Japan), is recommended for the initial EUS-guided drainage. For the immediate necrosectomy group, endoscopic necrosectomy (EN) will be performed in the same session of EUS-guided drainage using a gastroscope. The endoscope is inserted into the WON cavity through the LAMS, and necrotic tissue is removed using biopsy forceps, snare, or basket catheter. The EN procedures will be repeated until clinical improvement.

PROCEDUREStep-up approach

Endoscopic ultrasonography (EUS)-guided drainage will be conducted within 72 hours from randomization. A convex-type echoendoscope is advanced to the stomach or duodenum, and the walled-off necrosis (WON) is visualized and punctured under EUS guidance. A lumen-apposing metal stent (LAMS), such as Hot AXIOS system (Boston Scientific Japan, Tokyo, Japan), is recommended for the initial EUS-guided drainage. For the step-up approach group, an additional interventional procedure will be withheld for 72-96 hours after initial EUS-guided drainage. In cases without clinical improvement after 72-96 hours, additional drainage will be permitted, which includes increasing the number of stents, additional EUS-guided drainage, and performing percutaneous drainage (step-up treatment). Insufficient improvement even after two times of step-up treatment allows subsequent endoscopic necrosectomy (EN).


Locations(21)

Department of Gastroenterology, The University of Tokyo Hospital

Bunkyō-Ku, Tokyo, Japan

Department of Gastroenterology, Graduate School of Medicine, Juntendo University

Bunkyō-Ku, Tokyo, Japan

Department of Gastroenterology, Aichi Medical University

Aichi, Japan

Department of Gastroenterology, Graduate School of Medicine, Chiba University

Chiba, Japan

Department of Gastroenterology, Gifu Municipal Hospital

Gifu, Japan

Department of Gastroenterology, Gifu Prefectural General Medical Center

Gifu, Japan

First Department of Internal Medicine, Gifu University Hospital

Gifu, Japan

Division of Gastroenterology and Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo Medical University

Hyōgo, Japan

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University

Kagawa, Japan

Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences

Kagoshima, Japan

Department of Gastroenterology, Kameda Medical Center

Kamogawa, Japan

Department of Gastroenterological Endoscopy, Kanazawa Medical University

Kanazawa, Japan

Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University

Kawagoe, Japan

Department of Gastroenterology, Teikyo University Mizonokuchi Hospital

Kawasaki, Japan

Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine

Kobe, Japan

Department of Gastroenterology, Yuuai Medical Center

Okinawa, Japan

2nd Department of Internal Medicine, Osaka Medical College

Osaka, Japan

Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine

Ōsaka-sayama, Japan

Department of Gastroenterology and Hepatology, Hokkaido University Hospital

Sapporo, Japan

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine

Tokyo, Japan

Third Department of Internal Medicine, University of Toyama

Toyama, Japan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05451901


Related Trials